Gene · 4940
Papers2,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,054
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis. | J Neurovirol | 2023 | 37898570 | PubTator, text mining | PubMed |
| The Relationship between COVID-19 Severity in Children and Immunoregulatory Gene Polymorphism. | Viruses | 2023 | 37896870 | PubTator, text mining | PubMed |
| CRISPR-Cas system to discover host-virus interactions in Flaviviridae. | Virol J | 2023 | 37891676 | PubTator, text mining | PubMed |
| Proteomic and single-cell analysis shed new light on the anti-inflammatory role of interferonβ in chronic periodontitis. | Front Pharmacol | 2023 | 37876725 | PubTator, text mining | PubMed |
| Bavachin combined with epimedin B induce idiosyncratic liver injury under immunological stress conditions. | Chem Biol Interact | 2023 | 37866487 | PubTator, text mining | PubMed |
| Interaction of energy and sulfur microbial diet and smoking status with polygenic variants associated with lipoprotein metabolism. | Front Nutr | 2023 | 37860035 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy. | Signal Transduct Target Ther | 2023 | 37848421 | PubTator, text mining | PubMed |
| Occludin: a gatekeeper of brain Infection by HIV-1. | Fluids Barriers CNS | 2023 | 37840143 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease. | Cell Death Dis | 2023 | 37833251 | PubTator, text mining | PubMed |
| Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis. | Front Med (Lausanne) | 2023 | 37809329 | PubTator, text mining | PubMed |
| Editorial: Tumor microenvironment and cancer therapy. | Front Cell Dev Biol | 2023 | 37808077 | PubTator, text mining | PubMed |
| Obesity accelerates endothelial-to-mesenchymal transition in adipose tissues of mice and humans. | Front Cardiovasc Med | 2023 | 37795485 | PubTator, text mining | PubMed |
| The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality. | Front Oncol | 2023 | 37795443 | PubTator, text mining | PubMed |
| Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections. | Front Genet | 2023 | 37795240 | PubTator, text mining | PubMed |
| TRIM25 targets p300 for degradation. | Life Sci Alliance | 2023 | 37770115 | PubTator, text mining | PubMed |
| The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection-Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures. | Viruses | 2023 | 37766362 | PubTator, text mining | PubMed |
| Bioinformatics analysis to reveal the potential comorbidity mechanism in psoriasis and nonalcoholic steatohepatitis. | Skin Res Technol | 2023 | 37753698 | PubTator, text mining | PubMed |
| Type I/type III IFN and related factors regulate JEV infection and BBB endothelial integrity. | J Neuroinflammation | 2023 | 37752509 | PubTator, text mining | PubMed |
| The unique interplay of mitochondrial oxidative phosphorylation (OXPHOS) and immunity and its potential implication for the sex- and age-related morbidity of severe COVID-19 patients. | MedComm (2020) | 2023 | 37750090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4940/papers?page=9